Technology for Producing Hyperimmune Agglutinating Sera against Salmonella using Various Immunization Schemes and Studying the Biochemical and Immunological Parameters of the Sera
https://doi.org/10.31631/2073-3046-2025-24-4-77-85
Abstract
The spread of typhoid and paratyphoid fevers across all countries highlights their significance as a major public health concern (with Paratyphoid B also being relevant for veterinary medicine). The use of agglutinating diagnostic sera enables the serological identification of Salmonella bacteria through agglutination reactions. Purpose – to produce hyperimmune agglutinating sera against Salmonella using various immunization schemes and to study the biochemical and immunological parameters of the obtained serum samples. Materials and Methods. The following Salmonella strains were used for immunization (in the production of hyperimmune antisera): S. typhi 002140/4446, S. typhi 003788/18, S. typhi 003909/135, S. typhi 003901/418, S. typhimurium 004453/11, S. enteritidis 000571/867, S. paratyphi B 001150/34, S. anatum 001022/885, S. paratyphi A 000652/217. These strains were obtained from the National Collection of Pathogenic Microorganisms (Groups III-IV of human infections) at the Republican Specialized Scientific and Practical Medical Center of Epidemiology, Microbiology, Infectious and Parasitic Diseases (RSSPMCEIPD) of the Ministry of Health of the Republic of Uzbekistan. Corpuscular antigens of inactivated Salmonella strains were used for immunization. The hyperimmune sera were studied using bacteriological, biochemical, serological, and statistical methods. Results. Experimental research led to the creation of a bank of 72 diagnostic serum samples for Salmonella detection. The study of polyvalent diagnostic sera showed an increase in total protein, globulin, IgA, and IgG levels after the first, second, and third immunizations (on days 7, 14, and 21). Conclusion. Given that the levels of total protein, albumin, globulin, and IgG in the experimental animals peaked on day 28 of immunization, sera with high specific activity against various Salmonella strains can be obtained after four weeks.
About the Authors
L. N. TuychievUzbekistan
Laziz N. Tuychiev – Dr. Sci. (Med.), professor, Head of Infectious and Children’s Infectious Diseases Department; Leading Researcher
+998-71-214-83-11
Tashkent
B. M. Tadjiev
Uzbekistan
Botir M. Tadjiev – Dr. Sci. (Med.), professor, director; Head of the Department of Infectious Diseases, Pediatric Infectious Diseases, Phthisiology, and Pulmonology
+998-90-036-14-56
Tashkent
N. U. Tadjieva
Uzbekistan
Nigora U. Tadjieva – Dr. Sci. (Med.), Professor, Deputy Director for Science; Professor of the Infectious and Children’s Infectious Diseases
+998-71-243-3605
+998-90-355-5171
Tashkent
A. A-Т. Bektemirov
Uzbekistan
Amir A-Т. Bektemirov – Cand. Sci. (Med.), Senior Researcher
+9-9890-933-34-59
Tashkent
O. Sh. Kasimov
Uzbekistan
Odiljon Sh. Kasimov – Dr. Sci. (Med.), Leading Researcher of the Bacteriological Laboratory
+998-90-067-75-10
Tashkent
N. N. Karimova
Uzbekistan
Nigora N. Karimova – Laboratory Physician of the Clinical Diagnostic Laboratory
Tashkent
J. A. Anvarov
Uzbekistan
Jakhongir A. Anvarov – PhD, Associated professor of the Infectious and Children’s Infectious Diseases; Junior Researcher
+998-94-626-90-6
Tashkent
A. P. Yusupov
Uzbekistan
Yusupov Akmаl Pulatovich – PhD, Senior Lecturer at the Department of Medicine, Alfraganus University
+998-97-776-7168
Tashkent
References
1. Fonteneau L., Jourdan Da Silva N., Fabre L., et al. Multinational outbreak of travel-related Salmonella Chester infections in Europe, summers 2014 and 2015. Euro Surveill. 2017. Vol. 22, N7. P. 30463.
2. Als D., Radhakrishnan A., Arora P., et al. Global Trends in Typhoidal Salmonellosis: A Systematic Review. Am J Trop Med Hyg. 2018. Vol. 99, N3. P. 10–19.
3. Crump J.A., Sjölund-Karlsson M., Gordon M.A., et al. Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections. Clin Microbiol Rev. 2015. Vol. 28, N4. P. 901–937.
4. Kabwama S.N., Bulage L., Nsubuga F., et al. Correction to: A large and persistent outbreak of typhoid fever caused by consuming contaminated water and street-vended beverages: Kampala, Uganda, January - June 2015. BMC Public Health. 2017. Vol. 17, N1. P. 823.
5. Dyson Z.A., Klemm E.J., Palmer S., et al. Antibiotic Resistance and Typhoid. Clin Infect Dis. 2019. Vol. 68, N2. P. S165–S170.
6. Holt K.E., Phan M.D., Baker S., et al. Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid // PLoS Negl Trop Dis. 2011. Vol. 5, N7. P. e1245.
7. Mogasale V., Maskery B., Ochiai R.L., et al. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health. 2014. Vol. 2, N10. P. e570–e580.
8. Kinikar Anagha, Bhalerao Deepika, Roushani Shahriar, et al. The Easy and Early Diagnosis of Typhoid Fever. Journal of Clinical and Diagnostic Research. 2012. Vol. 6, N2. P. 198–199.
Review
For citations:
Tuychiev L.N., Tadjiev B.M., Tadjieva N.U., Bektemirov A.A., Kasimov O.Sh., Karimova N.N., Anvarov J.A., Yusupov A.P. Technology for Producing Hyperimmune Agglutinating Sera against Salmonella using Various Immunization Schemes and Studying the Biochemical and Immunological Parameters of the Sera. Epidemiology and Vaccinal Prevention. 2025;25(4):77-85. (In Russ.) https://doi.org/10.31631/2073-3046-2025-24-4-77-85